The cluster is routine in size and composition — no material signal for traders. The derivative-exercise-linked sales suggest tax/vesting mechanics, not informed selling. Monitor the next 8-K or earnings release for any fundamental changes, but this filing alone does not warrant a position adjustment.
Price Chart
Executive Summary
Three Jazz Pharmaceuticals insiders sold a total of $3.32M in open-market transactions over a 7-day window, including the Chief Commercial Officer and a Director. The sales are modest relative to the $14.2B market cap (~0.02%) and are partially offset by derivative exercises at lower strike prices, suggesting routine portfolio rebalancing rather than a bearish signal.
Key Financial Metrics
Key Facts
- Total insider sales: $3.32M across 3 insiders (Director, EVP Chief Commercial Officer, EVP Chief Legal Officer)
- Sales represent ~0.02% of Jazz's $14.2B market cap — well below the 0.1% materiality threshold
- Two of the three sales (Pearce and Mulligan) were paired with derivative exercises at $109.45 and $138.08, indicating tax-covering or cashless exercise patterns
- No insider purchases were reported in the cluster window
- Prior 30-day insider activity: 5 sells totaling $4.5M, consistent with ongoing routine selling
Financial Impact
Total insider sales of $3.32M represent 0.02% of market cap — immaterial
Risk Factors
- Insider selling could accelerate if management sees headwinds from Xywav/Xyrem patent cliffs or pipeline delays
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-JAZZ-1780521015525 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers